ARAY

Accuray Incorporated (ARAY) | Rumor.io

Accuray

ARAY

Attention (50-day avg)0%

Attention rank (50-day avg)#1,158

Bullish sentiment (50-day avg)93%

Price to earnings ratio-0.74

Market capitalization35.8M

Earnings per share-0.4

Dividend yield (TTM)—

Revenue (annual)401.9M

Net income (annual)-49.2M

Social

What share of all stock conversation is about ARAY?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.02% -0.1	0.02% new	0% +0	0% +0

Sep 29

Accuray Incorporated's stock may see news before the market opens, potentially well-timed.
The company's partnership with Samsung is seen as a positive development, with some investors predicting a significant increase in value.
Some analysts believe the stock is undervalued, with a 5-year chart suggesting a potential price of $5 or more.

Generated by AI

Sentiment

Of the messages about ARAY that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	86.29% -8.98	93.16%	93.16% -0.96	98.01% +12.12
Bearish	13.71% +8.98	6.84%	6.84% +0.96	1.99% -12.12

Bullish· Sep 29

The stock has the potential to reach $5+ in the long term, as seen in its 5-year chart.
The company has a strong future ahead, with the Cyberknife technology gaining traction and attracting big players like Samsung.
The stock has a high potential for growth, with the author confident in its ability to reach above $1 and potentially even $5+ in the near future.

Bearish· Sep 28

The asset's volume scanners may pick up on it due to over-sold conditions, potentially leading to a rebound.
A short position has been taken with a reported profit of $50k, and the asset is expected to continue its downward trend.
The asset's float is relatively small at around 118 million, and its high borrow rates on IBKR may make it an unattractive investment opportunity.

Generated by AI

Topics

Of the messages about ARAY that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	33.33%	32%	38.18%	52.59%
Technical Analysis	66.67%	68%	61.82%	18.28%
Earnings	0%	0%	0%	4.31%
Analysts	0%	0%	0%	13.1%
Controversies	0%	0%	0%	0%
Macro	0%	0%	0%	11.72%

Earnings· Oct 30

Accuray Incorporated ($ARAY) reported FQ1 earnings of -11c EPS and $95.83M Revs, missing the Estimize EPS Consensus by 4c.
$ARAY beat the Estimize Revenue Consensus by $0.06M, reporting $95.83M in revenue.
The company's loss of $0.07 per share was wider than the consensus estimate of a loss of $0.06 per share.

Analysts· Apr 30

Accuray Incorporated's hold rating was reiterated at BTIG Research.
Accuray Incorporated received a buy rating from Jefferies Group LLC with a $7.00 price target.
Accuray Incorporated's buy and hold ratings were reaffirmed by Jefferies Group LLC and BTIG Research, respectively.

Announcements· Apr 27

Accuray Incorporated (ARAY) reports record quarterly revenue of $118.1M, up 14.35%.
The company has achieved a 1,000+ installed system milestone, with 45% global product revenue growth YoY.
Accuray's Q3 earnings and revenues have surpassed estimates.

Generated by AI

Community

Of the messages about ARAY, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	17.44%	16.88%	16.9%	20.76%
Newcomers	82.56%	83.12%	83.1%	79.24%

Regulars· Sep 28

$ARAY is expected to break 34 near VWAP for the next leg of its price increase.
Accuray Incorporated, the company behind $ARAY, is expected to see its stock price go well over 1.00, with some predictions of it tripling in value short-term.
The Cyberknife technology, used by Accuray Incorporated, has been successful in treating stage 4 lung cancer, and its global adoption is anticipated to lead to significant gains in the stock price.

Newcomers· Sep 29

Newcomers are optimistic about Accuray Incorporated ($ARAY) and believe it has potential for growth, with one user noting that it's "not shorted much, is cheap to buy, and has a future."
Some newcomers are concerned about the stock's price action, with one user stating that a partnership with Samsung should have had a positive impact, but instead the stock got "shorted to hell."
Newcomers are looking for news and catalysts to drive the stock's price up, with several users mentioning the possibility of a positive announcement before the market opens, or a "turn" in the stock's price due to low volume.

Generated by AI

News

Why Is Accuray Stock Gaining Monday? - Accuray (NASDAQ:ARAY)

Accuray (ARAY) stock surged 42% premarket following a strategic CyberKnife imaging partnership with Samsung NeuroLogica.

1d agoBenzinga

Accuray partners with Samsung NeuroLogica on CyberKnife imaging

The agreements bring together mobile CT capabilities and precision treatment delivery expertise to improve anatomical visualisation during radiotherapy.

2d agoYahoo Finance

What Accuray’s (ARAY) $8 Million RaySearch Deal Means for Its Adaptive Therapy Push

Accuray Inc.’s (NASDAQ:ARAY) recent agreement with RaySearch Laboratories around an extended alliance, is a major step toward online adaptive radiation therapy. The integration of Accuray’s imaging technology and photon-based radiation therapy platforms with RaySearch’s proprietary planning and workflow solutions, will fast-track innovation across the space. For Accuray, the arrangement will also accelerate its adoption to […]

15d agoYahoo Finance Singapore

Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter

On August 19, Accuray Incorporated (NASDAQ:ARAY) held its fiscal fourth-quarter and full-year 2026 earnings call, laying out a business caught between a genuine financial rescue and a China market that is still bleeding revenue. Total net revenue fell 21% in the quarter to $100.9 million, and the company won’t even offer a forecast for the […]

1mo agoYahoo Finance

Accuray (ARAY) Q4 2026 Earnings Call Transcript

Motley Fool Press Release.

1mo agoThe Globe and Mail

Accuray Earnings Call: Service Strength Amid Product Strain

Tipranks Press Release.

1mo agotheglobeandmail.com

Also Discussed

Investors talking about ARAY also mention

#	Name	Attention
1	ENZ - Enzo Biochem, Inc.	——
2	Stereotaxis Inc.STXS	0%0
3	Edap Tms S.A.EDAP	0%0
4	American Vanguard CorpAVD	0%new
5	CSII - Cardiovascular Systems, Inc.	——
6	LexinFintech Holdings Ltd. ADRLX	0%0
7	TAST - Carrols Restaurant Group, Inc.	——
8	Outset Medical, Inc.OM	0%new
9	GraniteShares YieldBOOST CRCL ETFCRY	0%0
10	Highway Holdings LimitedHIHO	0%0

Accuray Incorporated

Healthcare
Medical Devices

Accuray Incorporated is a medical device company that develops, manufactures, sells, and supports advanced radiation therapy systems for cancer treatment. The company’s portfolio centers on the CyberKnife and Radixact platforms, which are designed to deliver precise, image-guided treatments for tumors and other complex clinical cases. Accuray also provides treatment planning software, motion management tools, and service offerings that support hospitals, cancer centers, and academic medical institutions. Its products are used across radiation oncology, stereotactic radiosurgery, and other specialized treatment workflows, giving the company a role in the broader market for precision oncology technologies. Accuray Incorporated focuses on combining hardware, software, and clinical support to help healthcare providers deliver targeted radiation therapy with greater accuracy and flexibility.

Website

Location

1240 Deming Way

Madison, WI, 53717-1954

United States

Social

What share of all stock conversation is about ARAY?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.02% -0.1	0.02% new	0% +0	0% +0

Sep 29

Accuray Incorporated's stock may see news before the market opens, potentially well-timed.
The company's partnership with Samsung is seen as a positive development, with some investors predicting a significant increase in value.
Some analysts believe the stock is undervalued, with a 5-year chart suggesting a potential price of $5 or more.

Generated by AI

Sentiment

Of the messages about ARAY that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	86.29% -8.98	93.16%	93.16% -0.96	98.01% +12.12
Bearish	13.71% +8.98	6.84%	6.84% +0.96	1.99% -12.12

Bullish· Sep 29

The stock has the potential to reach $5+ in the long term, as seen in its 5-year chart.
The company has a strong future ahead, with the Cyberknife technology gaining traction and attracting big players like Samsung.
The stock has a high potential for growth, with the author confident in its ability to reach above $1 and potentially even $5+ in the near future.

Bearish· Sep 28

The asset's volume scanners may pick up on it due to over-sold conditions, potentially leading to a rebound.
A short position has been taken with a reported profit of $50k, and the asset is expected to continue its downward trend.
The asset's float is relatively small at around 118 million, and its high borrow rates on IBKR may make it an unattractive investment opportunity.

Generated by AI

Topics

Of the messages about ARAY that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	33.33%	32%	38.18%	52.59%
Technical Analysis	66.67%	68%	61.82%	18.28%
Earnings	0%	0%	0%	4.31%
Analysts	0%	0%	0%	13.1%
Controversies	0%	0%	0%	0%
Macro	0%	0%	0%	11.72%

Earnings· Oct 30

Accuray Incorporated ($ARAY) reported FQ1 earnings of -11c EPS and $95.83M Revs, missing the Estimize EPS Consensus by 4c.
$ARAY beat the Estimize Revenue Consensus by $0.06M, reporting $95.83M in revenue.
The company's loss of $0.07 per share was wider than the consensus estimate of a loss of $0.06 per share.

Analysts· Apr 30

Accuray Incorporated's hold rating was reiterated at BTIG Research.
Accuray Incorporated received a buy rating from Jefferies Group LLC with a $7.00 price target.
Accuray Incorporated's buy and hold ratings were reaffirmed by Jefferies Group LLC and BTIG Research, respectively.

Announcements· Apr 27

Accuray Incorporated (ARAY) reports record quarterly revenue of $118.1M, up 14.35%.
The company has achieved a 1,000+ installed system milestone, with 45% global product revenue growth YoY.
Accuray's Q3 earnings and revenues have surpassed estimates.

Generated by AI

Community

Of the messages about ARAY, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	17.44%	16.88%	16.9%	20.76%
Newcomers	82.56%	83.12%	83.1%	79.24%

Regulars· Sep 28

$ARAY is expected to break 34 near VWAP for the next leg of its price increase.
Accuray Incorporated, the company behind $ARAY, is expected to see its stock price go well over 1.00, with some predictions of it tripling in value short-term.
The Cyberknife technology, used by Accuray Incorporated, has been successful in treating stage 4 lung cancer, and its global adoption is anticipated to lead to significant gains in the stock price.

Newcomers· Sep 29

Newcomers are optimistic about Accuray Incorporated ($ARAY) and believe it has potential for growth, with one user noting that it's "not shorted much, is cheap to buy, and has a future."
Some newcomers are concerned about the stock's price action, with one user stating that a partnership with Samsung should have had a positive impact, but instead the stock got "shorted to hell."
Newcomers are looking for news and catalysts to drive the stock's price up, with several users mentioning the possibility of a positive announcement before the market opens, or a "turn" in the stock's price due to low volume.

Generated by AI

Accuray

Social

Sep 29

Bullish· Sep 29

Bearish· Sep 28

Earnings· Oct 30

Analysts· Apr 30

Announcements· Apr 27

Regulars· Sep 28

Newcomers· Sep 29

Why Is Accuray Stock Gaining Monday? - Accuray (NASDAQ:ARAY)

Accuray partners with Samsung NeuroLogica on CyberKnife imaging

What Accuray’s (ARAY) $8 Million RaySearch Deal Means for Its Adaptive Therapy Push

Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter

Accuray (ARAY) Q4 2026 Earnings Call Transcript

Accuray Earnings Call: Service Strength Amid Product Strain

Also Discussed

Accuray Incorporated

Company Information

Location

Why Is Accuray Stock Gaining Monday? - Accuray (NASDAQ:ARAY)

Accuray partners with Samsung NeuroLogica on CyberKnife imaging

What Accuray’s (ARAY) $8 Million RaySearch Deal Means for Its Adaptive Therapy Push

Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter

Accuray (ARAY) Q4 2026 Earnings Call Transcript

Accuray Earnings Call: Service Strength Amid Product Strain

Also Discussed

Social

Sep 29

Bullish· Sep 29

Bearish· Sep 28

Earnings· Oct 30

Analysts· Apr 30

Announcements· Apr 27

Regulars· Sep 28

Newcomers· Sep 29